Bicara Therapeutics Inc (BCAX)

NASDAQ · Biotechnology

17.34
+0.00 (+0.00%)
Updated Oct 15, 1:15 PM ET
AI Rating
Sell
Overall Score
39
Trend
30
Momentum
50
Risk
38

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 1, 2025 260 sessions Oct 13, 2026

AI Analysis

Bicara Therapeutics Inc is trading at $17.34, up 0.00% on the session. The 50 day average sits at $22.31 and the 200 day at $21.29, which puts the stock in a uptrend. RSI is at 30.6, which reads as weak, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $15.85 with resistance near $23.34, so that band frames the current range. Average daily movement is roughly $1.15, or about 6.6% of the share price, which is what any stop placement has to allow for. The overall health score of 39 out of 100 combines a trend score of 30, momentum of 50 and a risk score of 38.

Technical indicators

RSI (14)
30.6
weak
MACD
-1.631
bullish crossover
SMA 20
19.15
SMA 50
22.31
SMA 200
21.29
uptrend
ATR (14)
1.15
avg daily range
Support
15.85
Resistance
23.34
Volume vs 20d
1.61x
volume spike
Volatility
52.3%
annualised
1 month
-25.26%
3 months
-38.33%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.